Self-referential processing during observation of a speech performance task in social anxiety disorder from pre- to post-treatment: Evidence of disrupted neural activation
- PMID: 30622047
- PMCID: PMC6415528
- DOI: 10.1016/j.pscychresns.2018.12.017
Self-referential processing during observation of a speech performance task in social anxiety disorder from pre- to post-treatment: Evidence of disrupted neural activation
Abstract
Self-referential processing is critical to understanding social anxiety disorder (SAD). This study examined neural differences in self-referential processing in healthy controls (HC) and participants with SAD at pre- and post-treatment. Participants (n = 64) underwent fMRI scanning while viewing a video of themselves ("Self") or another person ("Other"). SAD participants were randomized to cognitive behavior therapy (CBT), acceptance and commitment therapy (ACT), or waitlist, and were re-scanned at post-treatment. In SAD vs. HC, the fusiform face area (FFA) showed significantly more activation during Self vs. Other, and greater SAD severity was associated with significantly more activation during Self vs. Other in the right FFA and the left extrastriate body area (EBA). Greater reduction in SAD severity was associated with stronger connectivity between the amygdala and FFA during Self vs. Other at post-treatment, whereas the strength of connectivity during Self and Other was comparable at post-treatment for those with less SAD reduction. Thus, there were significant differences in activation and functional connectivity of brain regions implicated in self-referential processing in SAD. Change in connectivity between the amygdala and FFA were observed as a function of change in SAD severity, suggesting that improvements in SAD severity may correct this altered functional connectivity.
Keywords: Acceptance and commitment therapy; Cognitive behavior therapy; Self-referential processing; Social anxiety disorder.
Copyright © 2018. Published by Elsevier B.V.
Conflict of interest statement
Figures




Similar articles
-
Treatment for social anxiety disorder alters functional connectivity in emotion regulation neural circuitry.Psychiatry Res Neuroimaging. 2017 Mar 30;261:44-51. doi: 10.1016/j.pscychresns.2017.01.005. Epub 2017 Jan 16. Psychiatry Res Neuroimaging. 2017. PMID: 28129555 Free PMC article. Clinical Trial.
-
Changes in functional connectivity with cognitive behavioral therapy for social anxiety disorder predict outcomes at follow-up.Behav Res Ther. 2020 Jun;129:103612. doi: 10.1016/j.brat.2020.103612. Epub 2020 Mar 29. Behav Res Ther. 2020. PMID: 32276238 Free PMC article.
-
Neural responses to social threat and predictors of cognitive behavioral therapy and acceptance and commitment therapy in social anxiety disorder.Psychiatry Res Neuroimaging. 2017 Mar 30;261:52-64. doi: 10.1016/j.pscychresns.2016.12.012. Epub 2016 Dec 28. Psychiatry Res Neuroimaging. 2017. PMID: 28129556 Free PMC article.
-
Neuroimaging Predictors and Mechanisms of Treatment Response in Social Anxiety Disorder: an Overview of the Amygdala.Curr Psychiatry Rep. 2018 Aug 28;20(10):89. doi: 10.1007/s11920-018-0948-1. Curr Psychiatry Rep. 2018. PMID: 30155657 Free PMC article. Review.
-
The role of the acceptance and commitment therapy in the treatment of social anxiety: An updated scoping review.J Affect Disord. 2022 Aug 1;310:174-182. doi: 10.1016/j.jad.2022.05.008. Epub 2022 May 7. J Affect Disord. 2022. PMID: 35537544
Cited by
-
Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder.CNS Drugs. 2019 Oct;33(10):1031-1038. doi: 10.1007/s40263-019-00669-5. CNS Drugs. 2019. PMID: 31617149 Review.
-
Neural circuit basis of pathological anxiety.Nat Rev Neurosci. 2025 Jan;26(1):5-22. doi: 10.1038/s41583-024-00880-4. Epub 2024 Nov 27. Nat Rev Neurosci. 2025. PMID: 39604513 Review.
-
Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback.Neuropsychopharmacology. 2023 Apr;48(5):816-820. doi: 10.1038/s41386-022-01521-z. Epub 2022 Dec 23. Neuropsychopharmacology. 2023. PMID: 36564531 Free PMC article. Clinical Trial.
-
A systematic review and meta-analysis of acceptance- and mindfulness-based interventions for DSM-5 anxiety disorders.Sci Rep. 2021 Oct 14;11(1):20385. doi: 10.1038/s41598-021-99882-w. Sci Rep. 2021. PMID: 34650179 Free PMC article.
-
Neural Mechanisms of Cognitive Behavioral Therapy Efficacy in Anxiety Disorders: A Scoping Review of fMRI-Based Studies That Tested the Dual Model.Life (Basel). 2025 Mar 18;15(3):493. doi: 10.3390/life15030493. Life (Basel). 2025. PMID: 40141837 Free PMC article. Review.
References
-
- American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Publishing, Arlington, VA.